Table 1.

Patient demographic and medical characteristics by chemotherapy status.

	Total (n=93)		Chemo (n=49)		No chemo (n=44)
	%	n	%	n	%	n	p-value
Age at Baseline, mean (SD)	51.3 (7.8)		49.9 (8.5)		52.8 (6.7)		0.0685
Months from diagnosis to T1, mean (SD)	7.0 (2.8)		8.7 (2.4)		5.0 (1.6)		<0.0001
Race
White	85%	79	84%	41	86%	38	0.7172
Marital status
Married	71%	65	77%	37	64%	28	0.1571
Education
Post college	49%	46	49%	24	50%	22	0.9471
College	33%	31	35%	17	32%	14
Post HS	17%	16	16%	8	18%	8
WTAR, mean (SD)	113.8 (9.2)		113.8 (9.0)		113.9 (9.5)		0.9710
Employment
Full or part-time	61%	56	54%	26	68%	30	0.1688
Household Income
>$100K	70%	62	60%	28	81%	34	0.0285
BMI, mean (SD)	24.7 (4.5)		24.3 (4.6)		25.1 (4.4)		0.3922
Stage at Diagnosis
0	17%	16	0%	0	37%	16	<0.0001
1	45%	41	35%	17	56%	24
2	34%		57%	28	7%	3
3	4%		8%	4	0%	0
Surgery
Mastectomy	28%	26	33%	16	23%	10	0.2869
Lumpectomy	72%	67	67%	33	77%	34
Radiation
Yes	76%	71	80%	39	73%	32	0.4367
Hormone Replacement
Therapy
Yes	27%	24	21%	10	33%	14	0.1810
Change in period
Post-menopausal	48%	45	45%	22	52%	23	<0.0001
No change	18%	17	4%	2	34%	15
Became irregular	5%	5	0%	0	11%	5
Stop but resumed	3%	3	4%	2	2%	1
Amenorrhea	25%	23	47%	23	0%	0
Chemotherapy regimen:
Anthracycline
Yes	----	----	29%	14	----	----	----
Targeted Endocrine
Therapy at 6-month
Yes	72%	67	78%	38	66%	29	0.2117
If Yes, type:
Tamoxifen	54%	36	45%	17	66%	19	0.0910
Aromatase Inhibitor	46%	31	55%	21	34%	10

WTAR= Wechsler Test of Adult Reading; BMI=Body Mass Index